Question 1

What are the potential benefits of continuing with AV-101 in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my safety be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of AV-101?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

Question 6

Will there be any costs for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) clinical trial (NCT05557942). Contact the study team or your healthcare provider for specific answers.

What this study is about